ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,633Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 271

$1.34M Total Retail Price of All Prescriptions

Rank: 16 out of 271

734 Patients Receiving at Least One Drug in Part D
40%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 734 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 3,022 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$139 was the average price of a prescription from this provider, compared to $293 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
GABAPENTIN 828 226 1 2
TRAMADOL HCL 543 133 2 24
DIVALPROEX SODIUM ER 417 63 3 18
DONEPEZIL HCL 391 308 4 5
LYRICA 342 83 5 14
CITALOPRAM HBR 342 192 5 19
FLUOXETINE HCL 308 93 7 44
TIZANIDINE HCL 301 21 8 29
LEVETIRACETAM 300 69 9 3
SERTRALINE HCL 247 134 10 31
TOPIRAMATE 241 0 11 6
NAMENDA 234 205 12 8
HYDROCODONE-ACETAMINOPHEN 225 62 S3 13 4
LAMOTRIGINE 212 52 14 7
CARBAMAZEPINE 197 45 15 11
VIMPAT 192 13 16 17
NORTRIPTYLINE HCL 190 44 17 39
BACLOFEN 177 16 18 9
PRIMIDONE 170 141 19 12
DOXEPIN HCL 162 22 20 69
PAROXETINE HCL 145 83 21 62
DICLOFENAC SODIUM 135 14 22 115
CYMBALTA 126 32 23 27
MELOXICAM 122 51 24 39
BUPROPION XL 118 35 25 77
OXCARBAZEPINE 116 17 26 20
RISPERIDONE 109 64 27 50
MIRTAZAPINE 104 24 28 65
AMITRIPTYLINE HCL 102 0 R 29 23
ETODOLAC 98 12 30 96
NAPROXEN SODIUM 83 0 31 146
CYCLOBENZAPRINE HCL 82 0 R 32 25
ROPINIROLE HCL 82 51 32 16
CARBIDOPA-LEVODOPA 82 70 32 1
SULINDAC 79 0 35 147
METHOCARBAMOL 71 0 R 36 70
QUETIAPINE FUMARATE 67 23 37 51
TRAZODONE HCL 64 22 38 37
PROPRANOLOL HCL 59 20 39 34
EXELON 57 54 40 22
ORPHENADRINE CITRATE 54 0 R 41 119
DIVALPROEX SODIUM 52 17 42 13
NAPROXEN 51 0 43 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.